Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression
Abstract Background Sepsis is a life-threatening organ dysfunction caused by dysregulated host response to infection, and is primarily characterized by an uncontrolled systemic inflammatory response. In the present study, we developed an effective adjunct therapy mediated by a novel mechanism, to at...
Main Authors: | Wen-Feng Fang, Yu-Mu Chen, Chiung-Yu Lin, Hui-Lin Huang, Hua Yeh, Ya-Ting Chang, Kuo-Tung Huang, Meng-Chih Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | Journal of Inflammation |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12950-018-0179-6 |
Similar Items
-
Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer
by: Nikolaos Garmpis, et al.
Published: (2022-10-01) -
Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity
by: Hany S. Ibrahim, et al.
Published: (2021-12-01) -
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
by: Giorgio Milazzo, et al.
Published: (2020-05-01) -
Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke
by: Ying Tang, et al.
Published: (2017-10-01) -
Regulating the Regulators: The Role of Histone Deacetylase 1 (HDAC1) in Erythropoiesis
by: Min Young Kim, et al.
Published: (2020-11-01)